Pentixapharm Holding AG/ Total Voting Rights AnnouncementPentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution30.07.2026 / 22:46 CET/CESTTotal Voting Rights Announcement transmitted by EQS News - a ser…
Pentixapharm Holding AG/ Preliminary announcement on the disclosure of financial statementsPentixapharm Holding AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]27.07.2026 / 22:34 CET/CESTPreliminary anno…
Pentixapharm Holding AG/ Key word(s): Capital IncreasePentixapharm Completes Capital Increase – New Shares Placed in Full27.07.2026 / 20:50 CET/CESTThe issuer is solely responsible for the content of this announcement.Pentixapharm completes capital increase and raises total gross proceeds of approx…
Pentixapharm Holding AG / Key word(s): Capital measures / Capital increasePentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today27-Jul-2026 / 20:40 CET/CESTDisclosure of an inside…
Pentixapharm Holding AG/ Key word(s): StudyPentixapharm Receives FDA Fast Track Designation for Phase 3 Diagnostic Candidate [⁶⁸Ga]Ga-PentixaFor in Primary Aldosteronism09.07.2026 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Pentixapharm Receives FDA Fast Tr…
